Companies to reveal list price reductions to German authorities
This article was originally published in Scrip
Executive Summary
Pharmaceutical companies that fail to negotiate a price with German health insurers will likely have to disclose discounts or rebates in the 15 countries to be referenced by the arbitration board that will set German prices. The arbitration board says that companies must report the "actual price" in these countries.